Physician profile
Roy Rothman
NPI 1679550016
$1,397.45
in general payments reported to CMS, 2019-2025
25 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $41.97 · 2021: $45.42 · 2022: $50.13 · 2023: $327 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $258.78 | 2019-2025 | Collagenase Santyl, Stravix Pl, Regranex |
| Trilliant Surgical LLC. | $206.62 | 2019 | |
| Medtronic, INC. | $151.18 | 2023 | Hawkone, Intellis Adaptivestim |
| Sanara Medtech INC. | $135.88 | 2025 | Celleraterx |
| Reapplix INC. | $86.20 | 2025 | 3c Patch Kit - Box |
| Paragon 28, INC. | $80.50 | 2019 | |
| Stryker Corporation | $71.68 | 2019 | |
| Next Science LLC | $61.37 | 2023 | Blastx, Xperience, Surgx |
| Integra Lifesciences Corporation | $36.86 | 2019-2022 | |
| Boston Scientific Corporation | $31.78 | 2023 | |
| Bioventus LLC | $28.48 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $27.82 | 2019 | |
| Cashflow Solutions, LLC | $24.30 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Paratek Pharmaceuticals, INC. | $23.10 | 2021 | |
| Heron Therapeutics, INC. | $22.32 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $19.00 | 2025 | Miro3d |
| Organogenesis INC. | $18.17 | 2025 | Via Matrix |
| Cardiovascular Systems INC. | $17.95 | 2019 | |
| Stability Biologics, LLC | $17.81 | 2022 | |
| Convatec INC. | $16.84 | 2023 | |
| Globus Medical, INC. | $16.23 | 2025 | Senza |
| Averitas Pharma INC. | $13.72 | 2023 | Qutenza |
| Allergan, INC. | $13.28 | 2020 | |
| Kerecis Limited | $11.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Lifenet Health | $5.62 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Rothman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.